Our products
Our Portfolio
Therapeutic Areas
Nordic Pharma has a range of proprietary and in-licensed products in the following therapeutic areas: Women’s Health, Rheumatology, Critical Care.
Rheumatology
Nordimet® Pre-Filled Syringe (PFS)
Nordimet® / iMETH® / Zlatal® Pre-Filled Syringe
Nordimet® is a pre-filled syringe containing a solution of methotrexate.
Pharmacotherapeutic group: Antineoplastic and immunomodulating agents, other immunosuppressants.
Methotrexate is a folic acid antagonist which belongs to the class of cytotoxic agents known as antimetabolites. It acts by the competitive inhibition of the enzyme dihydrofolate reductase and thus inhibits DNA synthesis.*
*SmPC
For more information, click here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
Nordimet® Auto-Injector (AI)
Nordimet® Auto-Injector
Nordimet® pen is an auto-injector containing a solution of methotrexate.
Pharmacotherapeutic group: Immunosuppressants, other immunosuppressants. ATC code: L04AX03.
Methotrexate is a folic acid antagonist which belongs to the class of cytotoxic agents known as antimetabolites. It acts by the competitive inhibition of the enzyme dihydrofolate reductase and thus inhibits DNA synthesis.*
*SmPC
For more information, click here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
Women’s Health
Mifegyne®
Mifegyne®
Mifegyne® is a mifepristone drug.
Pharmacotherapeutic group: Other Sex Hormone and Modulator of the Reproductive function/Antiprogestogen
Mifepristone has an antiprogestin activity by acting as a competitive antagonist of the progesterone at the receptor level. It helps to increase myometrial contractility and to soften the cervix.*
*SmPC, which can be found here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
MisoOne®
MisoOne® / Topogyne® / Mispregnol®
MisoOne® is a misoprostol drug.
Pharmacotherapeutic class: Other gynaecological drugs, oxytocics – prostaglandins
Misoprostol is a prostaglandin analogue that triggers uterine contractions and relaxation of the cervix.*
*SmPC, which can be found here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
Hyalobarrier®
Hyalobarrier® Gel / Hyalobarrier® Gel Endo
Hyalobarrier® Gel and Hyalobarrier® Gel Endo are transparent and highly viscous gels made of 4% and 3% of auto-crosslinked polymer of hyaluronic acid, respectively, and provided in sterile single-use, pre-filled 10 mL syringes.
Hyalobarrier® is applied at the end of a surgery to the tissue surface and to the abdominal wall, creating an anti-adhesion barrier which keeps the adjacent tissues separated during the repair phase subsequent to a surgical procedure. It is a Class III medical device.
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the instruction for use (IFU). For advice on medical issues please consult your local medical practitioner.
checkToP®
checkToP®
checkToP® is an immunochromatographic low-sensitivity (1000 mIU/mL) urinary rapid test for the semi-quantitative detection of β-hCG (human chorionic gonadotropin) level in urine for home use. It is a Class I medical device.
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the instruction for use (IFU). For advice on medical issues please consult your local medical practitioner.
Critical Care
Trasylol®
Trasylol®
Trasylol® is an aprotinin solution.
Pharmacotherapeutic group: Antihemorrhagics, proteinase inhibitors
Aprotinin is a broad-spectrum protease inhibitor which has antifibrinolytic properties. This means that it stops the body breaking down blood clots.*
It is for adult use only.**
*https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-lifting-suspension-aprotinin
**SmPC, which can be found here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
Teysuno®
Teysuno®
Teysuno® (tegafur/gimeracil/oteracil) is a fluoropyrimidine anti-cancer medicinal product.
Pharmacotherapeutic group: Antineoplastic agents, antimetabolites
It is a fixed dose combination of three active substances, tegafur, which after absorption is converted into the anti-cancer substance 5-FU; gimeracil, a dihydropyrimidine dehydrogenase (DPD) inhibitor to prevent degradation of 5-FU by the body; and, oteracil, an orotate phosphoribosyltransferase (OPRT) inhibitor that decreases the activity of 5-FU in normal gastrointestinal mucosa.
Teysuno should only be prescribed by a doctor who is experienced in the use of cancer medicines.*
It is known in Asia as S-1.
*SmPC, which can be found here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
Ophthalmology
Clinitas
Clinitas
Our Clinitas portfolio is a is a range of lubricating eye drops used to relieve patients from symptoms of dry eye – e.g. grittiness, burning or foreign body sensation.
It comes in different formulations and presentations: Clinitas 0.2% and Clinitas 0.4% contain sodium hyaluronate and are available in uni- and multi-dose formats. Clinitas Gel contains carbomer. Clinitas products are class IIa medical devices
Biolon
Biolon
Biolon and Biolon Prime are ophthalmic viscoelastic devices (OVDs) containing 1% and 1.2% sodium hyaluronate respectively. Viscoelastic aid in cataract and other ophthalmic surgery. Their role is to maintain the anterior chamber and protect the corneal endothelium during the procedure. Biolon and Biolon Prime are class IIb medical devices.
Others
OTC Line Scandinavia
OTC Line Scandinavia
The OTC portfolio focuses on the gastrointestinal and common cold therapeutic areas. The portfolio consists of several well-known and market-leading brands, local as well as international. Nordic Pharma commercializes this range in Northern Europe.
More information here
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
Generics Line Scandinavia & CEE Region
Generics Line Scandinavia & CEE Region
The generic products represent a diversified portfolio in various therapeutic areas, namely oncology, pain relief and respiratory. Nordic Pharma commercializes this range mainly in Northern Europe and in the Central-Eastern European region.
Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Nordic Pharma Group. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information, please consult the summary of product characteristics (SmPC). For advice on medical issues please consult your local medical practitioner.
If you would like to report a side effect, click here
About Our Values